Logo image of BCAN

FEMTO TECHNOLOGIES INC (BCAN) Stock Fundamental Analysis

NASDAQ:BCAN - Nasdaq - CA31447N2041 - Common Stock - Currency: USD

4.2  +0.21 (+5.26%)

After market: 4.43 +0.23 (+5.48%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BCAN. BCAN was compared to 284 industry peers in the Software industry. While BCAN has a great health rating, there are worries on its profitability. BCAN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BCAN has reported negative net income.
BCAN had a negative operating cash flow in the past year.
In the past 5 years BCAN always reported negative net income.
In the past 5 years BCAN reported 4 times negative operating cash flow.
BCAN Yearly Net Income VS EBIT VS OCF VS FCFBCAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

BCAN's Return On Assets of -150.38% is on the low side compared to the rest of the industry. BCAN is outperformed by 94.24% of its industry peers.
BCAN has a worse Return On Equity (-1745.00%) than 88.13% of its industry peers.
Industry RankSector Rank
ROA -150.38%
ROE -1745%
ROIC N/A
ROA(3y)-39.57%
ROA(5y)-35.71%
ROE(3y)-42.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCAN Yearly ROA, ROE, ROICBCAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 400 600

1.3 Margins

BCAN's Gross Margin of 2.83% is on the low side compared to the rest of the industry. BCAN is outperformed by 89.21% of its industry peers.
BCAN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BCAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.87%
GM growth 5Y15.47%
BCAN Yearly Profit, Operating, Gross MarginsBCAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

7

2. Health

2.1 Basic Checks

BCAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BCAN has been increased compared to 1 year ago.
The number of shares outstanding for BCAN has been increased compared to 5 years ago.
The debt/assets ratio for BCAN has been reduced compared to a year ago.
BCAN Yearly Shares OutstandingBCAN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50K 100K 150K 200K
BCAN Yearly Total Debt VS Total AssetsBCAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

BCAN has an Altman-Z score of -3.23. This is a bad value and indicates that BCAN is not financially healthy and even has some risk of bankruptcy.
BCAN has a worse Altman-Z score (-3.23) than 80.94% of its industry peers.
There is no outstanding debt for BCAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.23
ROIC/WACCN/A
WACC9.69%
BCAN Yearly LT Debt VS Equity VS FCFBCAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 9.11 indicates that BCAN has no problem at all paying its short term obligations.
With an excellent Current ratio value of 9.11, BCAN belongs to the best of the industry, outperforming 96.04% of the companies in the same industry.
BCAN has a Quick Ratio of 9.11. This indicates that BCAN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BCAN (9.11) is better than 96.04% of its industry peers.
Industry RankSector Rank
Current Ratio 9.11
Quick Ratio 9.11
BCAN Yearly Current Assets VS Current LiabilitesBCAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

BCAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -642.42%.
BCAN shows a decrease in Revenue. In the last year, the revenue decreased by -7.81%.
The Revenue has been decreasing by -6.94% on average over the past years.
EPS 1Y (TTM)-642.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.43%
Revenue 1Y (TTM)-7.81%
Revenue growth 3Y-7.07%
Revenue growth 5Y-6.94%
Sales Q2Q%-49.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BCAN Yearly Revenue VS EstimatesBCAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BCAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BCAN Price Earnings VS Forward Price EarningsBCAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCAN Per share dataBCAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BCAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FEMTO TECHNOLOGIES INC

NASDAQ:BCAN (1/27/2025, 8:00:00 PM)

After market: 4.43 +0.23 (+5.48%)

4.2

+0.21 (+5.26%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2024-08-08
Earnings (Next)N/A N/A
Inst Owners5.04%
Inst Owner Change20761.2%
Ins Owners30.02%
Ins Owner ChangeN/A
Market Cap2.77M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.9
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-103.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.19
FCFYN/A
OCF(TTM)-6.18
OCFYN/A
SpS1.08
BVpS3.1
TBVpS-26.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -150.38%
ROE -1745%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.83%
FCFM N/A
ROA(3y)-39.57%
ROA(5y)-35.71%
ROE(3y)-42.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.87%
GM growth 5Y15.47%
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.11
Quick Ratio 9.11
Altman-Z -3.23
F-Score3
WACC9.69%
ROIC/WACCN/A
Cap/Depr(3y)1182.13%
Cap/Depr(5y)727.83%
Cap/Sales(3y)38.85%
Cap/Sales(5y)23.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-642.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.81%
Revenue growth 3Y-7.07%
Revenue growth 5Y-6.94%
Sales Q2Q%-49.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-191.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-212.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-738.56%
OCF growth 3YN/A
OCF growth 5YN/A